A Study of BMS-986504 With Standard-of-Care Therapy for People With Solid Tumor Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to 5-FU
Related studies linked through entity extraction aliases.
A Study Evaluating the Safety and Efficacy of JS212 Combination Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of the Preliminary Efficacy and Safety of DR30206 in Combination With Standard Therapy in Patients With Gastrointestinal Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
A Irinotecan Liposome Trial of in Advanced Neuroendocrine Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Preoperative Chemoradiotherapy Combined With Consolidation or Induction NALIRIFOX in Rectal Cancer.
- Status
- RECRUITING
- Phase
- NA
ARTEMIS-102: HS-20093 Combinations in Patients with Advanced Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of HCB101 in Combination With Multiple Agents in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
First-line Treatment With RC48 Plus Sintilimab and S-1 in Advanced Gastric Cancer (RCTS2)
- Status
- RECRUITING
- Phase
- PHASE2
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Phase II Study of Irinotecan Liposomes in First-line Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Perioperative Treatment in High-risk Resectable Pancreatic Cancer With NALIRIFOX
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer
- Status
- RECRUITING
- Phase
- PHASE2